| [1] |
屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读. 结核与肺部疾病杂志, 2025, 6 (6): 613-623. doi:10.19983/j.issn.2096-8493.20250178.
|
| [2] |
Thu WPP, Hu TH, D’Ambrosio L, et al. Charting the Course in Post-Tuberculosis Lung Disease: From Inflammation to Intervention. Arch Bronconeumol, 2025, 61 (12): 757-765. doi:10.1016/j.arbres.2025.09.017.
|
| [3] |
盛子康, 盖晓燕, 孙永昌. 结核后肺疾病的异质性特征及综合管理进展. 中华结核和呼吸杂志, 2025, 48(2):181-185. doi:10.3760/cma.j.cn112147-20240701-00375.
|
| [4] |
Silva DR, Mello FCQ, Galvão TS, et al. Pulmonary Rehabilitation in Patients With Post-Tuberculosis Lung Disease: A Prospective Multicentre Study. Arch Bronconeumol, 2025, 61(10): 603-609. doi:10.1016/j.arbres.2025.02.007.
|
| [5] |
Meghji J, Simpson H, Squire SB, et al. A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease. PLoS One, 2016, 11(8):e0161176. doi:10.1371/journal.pone.0161176.
|
| [6] |
Allwood BW, Byrne A, Meghji J, et al. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration, 2021, 100(8):751-763. doi:10.1159/000512531.
|
| [7] |
Amaral AF, Coton S, Kato B, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J, 2015, 46(4):1104-1112. doi:10.1183/13993003.02325-2014.
pmid: 26113680
|
| [8] |
Liang Y, Yangzom D, Tsokyi L, et al. Clinical and Radiological Features of COPD Patients Living at ≥3000 m Above Sea Level in the Tibet Plateau. Int J Chron Obstruct Pulmon Dis, 2021, 16:2445-2454. doi:10.2147/COPD.S325097.
|
| [9] |
Bisson GP, Allwood B, Byrne A, et al. Post-tuberculosis lung disease: a case definition for use in research studies. Lancet Infect Dis, 2025: S1473- 3099(25)00548-1. doi:10.1016/S1473-3099(25)00548-1.
|
| [10] |
Nataprawira HM, Dewi IMW, Wiraningrat IGAAN, et al. Imaging of post-tuberculosis lung disease cases in children and adolescent survivors: a systematic review. Eur Clin Respir J, 2025, 12 (1): 2547515. doi:10.1080/20018525.2025.2547515.
|
| [11] |
da Silva MPVL, da Silva Pinto PVL, Fonseca IMPP, et al. Correlations between exercise oxygen consumption, lung function, image findings, and quality of life in adults with post-tuberculosis lung disease. Chron Respir Dis, 2025, 22: 14799731251345492. doi:10.1177/14799731251345492.
|
| [12] |
Zhang Y, Gai X, Rao Y, et al. Pre-treatment blood cell counts and inflammatory markers predict the radiologic severity of post-tuberculosis lung disease. BMC Infect Dis, 2025, 25(1):1384. doi:10.1186/s12879-025-11782-w.
|
| [13] |
Almubarek M, Louw EH, Griffith-Richards S, et al. Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease. Afr J Thorac Crit Care Med, 2025, 31(1):e1948. doi:10.7196/AJTCCM.2025.v31i1.1948.
|
| [14] |
Silva DR, Santos AP, Visca D, et al. Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease. J Bras Pneumol, 2024, 49(6):e20230269. doi:10.36416/1806-3756/e20230269.
|
| [15] |
张培泽, 赵曼曼, 魏方军, 等. 肺结核后慢性肺曲霉病诊治专家共识. 新发传染病电子杂志, 2024, 9(6):74-84. doi:10.19871/j.cnki.xfcrbzz.2024.06.014.
|
| [16] |
Yadav S, Rawal G. Understanding the Spectrum and Management of Post-Tuberculosis Lung Disease: A Comprehensive Review. Cureus, 2024, 16(6):e63420. doi:10.7759/cureus.63420.
|
| [17] |
Nkereuwem E, Agbla S, Sallahdeen A, et al. Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study. Thorax, 2023, 78(3): 281-287. doi:10.1136/thorax-2022-219085.
|
| [18] |
Fumagalli G, Mencarini J, Sini I, et al. Post-tuberculosis lung disease: a guide for clinicians. Infection, 2026, 54(1): 15-24. doi:10.1007/s15010-025-02645-2.
|
| [19] |
Myers H, Chongo B, Zifodya JS, et al. Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type Ⅲ effectiveness-implementation study protocol. BMC Pulm Med, 2024, 24(1): 502. doi:10.1186/s12890-024-03329-7.
|
| [20] |
Seo W, Kim HW, Kim JS, et al. Long term management of people with post-tuberculosis lung disease. Korean J Intern Med, 2024, 39(1):7-24. doi:10.3904/kjim.2023.395.
pmid: 38225822
|
| [21] |
Malefane L, Maarman G. Post-tuberculosis lung disease and inflammatory role players: can we characterise the myriad inflammatory pathways involved to gain a better understanding?. Chem Biol Interact, 2024, 387:110817. doi:10.1016/j.cbi.2023.110817.
|
| [22] |
Gai X, Allwood B, Sun Y. Advances in the awareness of tuberculosis-associated chronic obstructive pulmonary disease. Chin Med J Pulm Crit Care Med, 2024, 2(4): 250-256. doi:10.1016/j.pccm.2024.08.008.
pmid: 39834582
|
| [23] |
Chakaya J. Post-tuberculosis lung disease: understanding risk factors and mechanisms to target interventions. Thorax, 2026, 81(2): 112-113. doi:10.1136/thorax-2025-223534.
|